Skip to main content
Clinical Trials/NL-OMON55535
NL-OMON55535RecruitingPhase 3

Cost-effectiveness of perioperative vaginally administered oestrogen in postmenopausal women undergoing prolapse surgery. - EVA trial

Academisch Medisch Centrum0 sites300 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Postmenopausal women (>1 year amenorrhoea) with a minimum age of 18 years old
  • - Pelvic organ prolapse; POP Quantification stage 2 or higher
  • - Women that will undergo primary POP surgery with native tissue repair;
  • including at least anterior OR posterior vaginal wall repair

Exclusion Criteria

  • - Previous POP surgery in concerning compartment
  • - Prolapse repair using mesh
  • - Current vaginal infection
  • - Use of oestrogens in the past 12 months
  • - Contraindication for use of topical oestrogen
  • - Known, past or suspected oestrogen-dependent malignant tumours (e.g. breast
  • cancer, endometrial cancer);
  • - Insufficient knowledge or understanding of the Dutch language

Investigators

Similar Trials

Cost-effectiveness of perioperative... | Clinical Trial